Sven Thormahlen

Plus aucun poste en cours

68 ans

Consumer Non-Durables

Health Technology

Consumer Services

Profil

Dr. Sven Thormahlen is Chief Technology Officer at Corbion NV.
He is on the Board of Directors at Accera, Inc. Dr. Thormahlen was previously employed as Executive Vice President-Research & Development by Danone SA, Chief Executive Officer by MucoVax GmbH, Outside Director by Yakult Honsha Co., Ltd., and Senior Vice President-Research & Development by L'Oréal SA. He received his graduate degree from the University of Hamburg and a doctorate degree from the University of Hamburg.

Anciens postes connus de Sven Thormahlen

Sociétés	Poste	Fin
MucoVax GmbH	Chief Executive Officer	-
CORBION N.V.	Chief Tech/Sci/R&D Officer	-
L'ORÉAL	Chief Tech/Sci/R&D Officer	-
Cerecin, Inc. Cerecin, Inc. Pharmaceuticals: MajorHealth Technology Cerecin, Inc. develops therapies to treat central nervous system disorders. It offers therapeutic treatments for Parkinson's disease, Alzheimer's disease, and other age-related memory loss disorders. The firm is also developing therapies that address metabolic deficiencies and provide an alternative energy source for brain cells. The company was founded in 2001 and is headquartered in Boulder, CO.	Director/Board Member	-
YAKULT HONSHA CO.,LTD.	Director/Board Member	-

Voir l'expérience en détail de Sven Thormahlen

Formation de Sven Thormahlen

University of Hamburg

Doctorate Degree

Expériences
Fonctions occupées

Actives

Inactives

Sociétés cotées

Entreprise privées